Centiva Capital, LP Inovio Pharmaceuticals, Inc. Transaction History

Centiva Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $21,217 - $51,140	54,405 New	54,405 $24,000
Q2 2021 Aug 16, 2021	SELL	$6.23 - $10.03 $127,696 - $205,584	-20,497 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.81 - $16.96 $76,567 - $147,399	8,691 Added 73.62%	20,497 $190,000
Q4 2020 Feb 16, 2021	SELL	$8.5 - $12.85 $12,393 - $18,735	-1,458 Reduced 10.99%	11,806 $104,000
Q3 2020 Nov 16, 2020	BUY	$9.57 - $27.05 $126,936 - $358,791	13,264 New	13,264 $154,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.